edited by Martha M. Eibl, Christoph Huber, Hans H. Peter, Ulrich Wahn.
Berlin
Heidelberg Springer Berlin Heidelberg
1997
(XI, 172 p. 14 illus.)
T Cell Recognition and CD95-Associating Signalling --; Characterization of Antigens Recognized by T Cells on Human Tumors --; Shared and Individual CTL-Defined Antigens on Human Melanoma Cells --; Deficiencies of the MHC Class I Antigen Processing and Presentation Machinery in Tumor Cells --; The Use of HLA Transgenic Mice in Identifying and Targeting Human Tumor Cell Antigens --; CD95-Associating Signaling Molecules --; Clinical Investigations: Cells, Costimulatory Signals --; Adoptive Immunotherapy in Chimeras --; Towards the Development of Immunogenic Colon Cancer Cells for Immunotherapy --; Gene-Modified Dendritic Cells as Vaccines for the Induction of Anti-Tumor Immunity --; Potent Presentation of Soluble Protein Antigens by In Vitro-Generated Dendritic Cells from Peripheral Blood CD34+ Progenitor Cells --; Therapeutic Approaches: Cytokines and Vaccines --; Interleukin-12: Biology and Clinical Studies --; Peptide Vaccines in Melanoma Patients --; Ras Peptide Vaccines --; Idiotype-Based Immunotherapy of Cancers --; Heat-Shock-Protein-Based Vaccines against Cancers and Intracellular Infections.
This is the sixth symposium in a series of symposia on immunology organized by IMMUNO covering this time tumor immunology. This volume deals with T cell recognition and CD95-associating signaling, clinical investigations: cells, costimulatory signals and therapeutic approaches: cytokines and vaccines.
Biology.
Health & Biological Sciences.
Tumors -- Immunological aspects -- Congresses.
QR188
.
6
E358
1997
edited by Martha M. Eibl, Christoph Huber, Hans H. Peter, Ulrich Wahn.